Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.64
$0.092.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.31% | -55.35% | -59.45% | -35.44% | -43.14% |
| Total Depreciation and Amortization | -72.03% | -76.36% | -62.54% | 13.94% | 21.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18,016.78% | 1,729.26% | 830.77% | 37.20% | -88.86% |
| Change in Net Operating Assets | -212.79% | -107.12% | -66.16% | -8.59% | 33.31% |
| Cash from Operations | -15.76% | -19.06% | -26.08% | -31.32% | -38.33% |
| Capital Expenditure | 47.50% | 47.50% | -1,433.33% | -105.56% | -166.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 46.56% | 212.80% | 308.68% | 262.45% |
| Cash from Investing | -100.05% | 46.75% | 212.70% | 308.21% | 262.20% |
| Total Debt Issued | -- | -- | -1.12% | -- | -- |
| Total Debt Repaid | -- | -- | -400.00% | -- | -- |
| Issuance of Common Stock | 3,972.95% | 265.18% | -12.39% | -98.39% | -97.85% |
| Repurchase of Common Stock | 100.00% | -- | -207.41% | -207.41% | -207.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 4,109.40% | -- | -- |
| Cash from Financing | 5,851.16% | 371.92% | -28.09% | -99.14% | -98.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.69% | 218.06% | 977.93% | -209.52% | -171.93% |